TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer

BACKGROUND: Gastric cancer (GC) is a heterogeneous disease that encompasses various molecular subtypes. The molecular mutation characteristics of circulating tumor DNA (ctDNA) in advanced gastric cancer (AGC), especially the clinical utility of TP53 mutation and MET amplification in ctDNA need to be...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PeerJ
Hoofdauteurs: Li, Jia, Li, Zhaoyan, Ding, Yajie, Xu, Yan, Zhu, Xiaohong, Cao, Nida, Huang, Chen, Qin, Mengmeng, Liu, Feng, Zhao, Aiguang
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: PeerJ Inc. 2021
Onderwerpen:
Bioinformatics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8054733/
https://ncbi.nlm.nih.gov/pubmed/33959414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.11146
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items